Cardiovascular risk: a UK priority--it's time to act II
نویسندگان
چکیده
منابع مشابه
A time to act.
It’s been 1 year since the American Medical Association closed the Center for Disaster Medicine and Public Health and stopped supporting its preparedness and response programs. To ensure the continuation and potential growth of these programs as vital components of the evolving discipline of disaster medicine and public health, 2 major transitions were undertaken. The first was to revise the Na...
متن کاملObstructive sleep apnea and cardiovascular disease - time to act!
Sleep related breathing disorders are common and their potential to disrupt sleep leading to daytime fatigue and hypersomnolence is widely acknowledged. In the future, obstructive sleep apnoea (OSA) may become even more important because obesity as a main risk factor is increasingly prevalent. Apart from disturbing sleep, OSA has also been recognised as a risk factor for hypertension, acute car...
متن کاملTakeHeart II: A tool to support clinical cardiovascular risk assessment
Bayesian networks are powerful reasoning engines for decision support systems, due to their accomodation for a wide range of queries, and clear presentation of independence assumptions. However, their practical use hinges on an accessible presentation of the knowledge they represent: a user should be exposed to only the functionality they need to get their job done. We desired to build a softwa...
متن کاملPrehypertension - time to act.
The term "prehypertension" defined as systolic blood pressure between 120 and 139 mmHg and/or diastolic pressures between 80 and 89 mmHg has now gained general acceptance. Prehypertension is associated with ~3-fold greater likelihood of developing hypertension, and roughly twice the number of cardiovascular events, than BP < 120/80 mmHg. When compared with normotensive individuals, prehypertens...
متن کاملCOMMENTARY Time to Act on the Inadequate Management of Wernicke’s Encephalopathy in the UK
Wernicke’s encephalopathy (WE) is a serious medical emergency whose pathogenesis is well understood and reviewed in this paper. Summarizing the evidence for its prophylaxis and management, the authors suggest that, in the UK, there is evidence that many patients identified as being at risk of WE currently do not receive appropriate treatment, despite the availability (not universal) of guidelin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2004
ISSN: 0007-0769
DOI: 10.1136/hrt.2004.037515